Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis

Patients with kidney failure have notoriously weak responses to common vaccines. Thus, immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine immunogenicity of SARS-CoV-2 vaccination in patients with chronic dialysis, we analyzed the humoral and T-cell response aft...

Full description

Bibliographic Details
Main Authors: Eva Schrezenmeier, Leon Bergfeld, David Hillus, Joerg-Detlev Lippert, Ulrike Weber, Pinkus Tober-Lau, Irmgard Landgraf, Tatjana Schwarz, Kai Kappert, Ana-Luisa Stefanski, Arne Sattler, Katja Kotsch, Thomas Dörner, Leif Erik Sander, Klemens Budde, Fabian Halleck, Florian Kurth, Victor Max Corman, Mira Choi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
vaccination
COVID – 19
dialysis
antibody response
SARS – CoV – 2
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.690698/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.690698/full

Similar Items